PROFUSA, INC. Convertible Debt, Current
PROFUSA, INC. (PFSA) had Convertible Debt, Current of $8.21 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2026-08-19
- 2026-06-30: Convertible Debt, Current $8.21M.
- 2026-03-31: Convertible Debt, Current $7.02M.
- 2025-12-31: Convertible Debt, Current $42.00K; Convertible Debt, Current as first filed $4.20M.
- 2025-09-30: Convertible Debt, Current $4.28M.
| Period end | Convertible Debt, Current | Convertible Debt, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.21M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $7.02M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $42.00K 10-Q · filed 2026-08-19 | $4.20M 10-K · filed 2026-04-15 |
| 2025-09-30 | $4.28M 10-Q · filed 2025-11-19 | |
| 2025-03-31 | $1.50M 10-Q · filed 2025-06-13 | |
| 2024-12-31 | $45.92M S-1/A · filed 2026-05-01 | $1.50M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.50M 10-Q · filed 2024-12-17 | |
| 2024-06-30 | $1.50M 10-Q · filed 2024-11-15 | |
| 2024-03-31 | $1.50M 10-Q · filed 2024-10-09 | |
| 2023-12-31 | $1.50M 10-K · filed 2024-02-26 | |
| 2023-09-30 | $1.50M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $1.50M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.50M 10-Q · filed 2023-05-17 | |
| 2022-12-31 | $1.50M 10-K · filed 2023-03-06 | |
| 2022-09-30 | $1.50M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.50M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.50M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.50M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |